We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| AL Noor Hosp. | ANH | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 892.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 892.00 | 892.00 |
| Top Posts |
|---|
Posted at 11/2/2016 13:18 by liam1om 328 Dividend today WW. |
Posted at 15/10/2015 13:35 by yet another final NMC will not put in hostile offer Realistically mediclinic tie up is the better option for both--note comment of earnings neutral in RNS.NMC would take out AlNoor and then cost cut like mad... Cheaper for them (NMC) to continue with their own expansion strategyANH is too big and uneconomical, needs to slim down (dependently or independently)IMHO the current offer is very generous |
Posted at 12/5/2015 23:16 by futurdoc Of course Aishahq, ANH is still growing albeit at a slower rate than in previous year and slower than the market expected.Yes that would be interesting, using their cash pile and making an EPS enhancing acquisition would be exciting. Just how they don't slaught their balance sheet to do so if they do so. I will be surprised if such a deal is done without a CFO though. We shall see what unfolds. |
Posted at 12/5/2015 16:52 by futurdoc I had been watching this and NMC since Jan, ANH more closely as I felt it was the better company of the two (better margins, debt free) but the share prices since tell a different story!The director speak has changed from UAE has one of fastest growing healthcare markets etc to we're watching our competitors etc. Revenue growth has slowed from 24% Y on Y(Q1'13 to Q1 14) to 11.9% (Q1'14 to Q1'15) margins are thankfully stable after slipping last year. EPS was downgraded recently from 58p to 54p. The number of physicians (previously an important KPI) at quarter end wasn't reported. Concerning as this is the past has been a good proxy for growth. CEO and now CFO have left in the last 12 months. New Chief medical officer too. Large shareholders sold out completely in the last month too. No wonder the share price has reacted soo poorly. Overall, I'm cautious and I will await the interim numbers before making a decision. £7.00 (PE 13, 54p EPS) would interest me, as that would provide some margin of safety against further falls. But then again, the forecast EPS could drop further. We shall see. |
Posted at 16/4/2015 14:20 by admin900 Dividend day lol share price look strong 10 soon. |
Posted at 30/3/2015 10:08 by mapmagic The dividend is not huge, but it pays one and its been increased over 30% on last year. I'd prefer them to use the big cash pile they have on acquisitions and growing the business so very happy with their strategy.I take it if you have conviction in that these are heading to £9, you have a massive short so you can profit cyman? Of course you don't. Because you know they are a super company with great prospects. And therefore the share price can only rise over time. |
Posted at 30/3/2015 09:56 by cyman More like heading back to 9Ridiculous low dividend |
Posted at 30/3/2015 07:47 by mapmagic Super results! Profits, EBITDA and revenue all strongly up and great outlook for the the future. Well done ANH! |
Posted at 24/3/2015 16:28 by mapmagic Indeed gucci. All looks good for results next week. If NMC are anything to go by, ANH will be pushing to new highs and deservedly so! |
Posted at 05/3/2015 12:01 by gohil18 I note how NMC is up over over 15% since its results. NMC is not only more expensive than ANH on a PBT to MCAP basis, they also have debt where NMC has a nice big net cash position. Interestingly, the broker Jeffries cover's both and reiterated and upped their target on NMC after their results. NMC rose more than 7% on that day alone and are hitting new highs.It's likely Jeffries will do the same for ANH once the results are published, which from the trading update know will be good. So onwards and upwards. Expect at least £12 in the short term back to previous highs, but between £14-16 in a medium time frame from ANH. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
